Biodegradable magnesium alloy blood vessel rack

A magnesium alloy blood vessel and biodegradation technology, applied in stents, medical science, prostheses, etc., can solve problems such as acute or chronic inflammatory reactions, uncertain plastic deformation points of polymers, and disordered growth of vascular endothelial cells. Achieving excellent mechanical properties, good biocompatibility, and grain refinement

Active Publication Date: 2007-01-03
LIAONING YINYI BIOTECH CO LTD
View PDF0 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the main materials used to make vascular stents at home and abroad are stainless steel, titanium-nickel alloy and cobalt-chromium alloy, but these permanent metal stents will have the following disadvantages during the long-term implantation process: The permanent implant remains on the inner wall of the blood vessel, and the physical stimulation of the tension that does not match the blood vessel becomes a one-way side effect foreign body. Long-term stimulation causes the growth disorder of vascul

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0020] Example 1:

[0021] A biodegradable magnesium alloy vascular stent, its weight percentage composition is: zinc 5%-8%; calcium 0.5-5%; zirconium 1%-3%; neodymium 1%-3%; niobium 0-3%, The rest is magnesium. Its physical and chemical properties, especially its degradability can be adjusted by adding other metal elements with good biocompatibility; especially its degradability can be adjusted by adding other rare earth elements with good biocompatibility ; Its biocompatibility can be adjusted by adding other metal elements with good biocompatibility and rare earth elements; its processability can be adjusted by adding other metal elements with good biocompatibility.

Example Embodiment

[0022] Example 2:

[0023] A biodegradable magnesium alloy vascular stent is composed of 7% by weight of zinc; 0.5% of calcium; 1% of zirconium; 1% of neodymium; and the rest is magnesium. After further processing the shaped material, the physical properties of the material are measured as follows: tensile strength is 220Mpa; elastic modulus is 20Gpa; elongation at break is 8%; in vitro degradation half-life is 8 weeks.

Example Embodiment

[0024] Example 3:

[0025] A biodegradable magnesium alloy vascular stent is composed of 5% zinc; 2% calcium; 3% zirconium; 3% neodymium; 3% niobium, and the rest is magnesium. After further processing the shaped material, the physical properties of the material are measured as follows: the tensile strength is 270Mpa; the elastic modulus is 35Gpa; the elongation at break is 5%; the in vitro degradation half-life is 12 weeks.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Tensile strengthaaaaaaaaaa
Elastic modulusaaaaaaaaaa
Tensile strengthaaaaaaaaaa
Login to view more

Abstract

The biodegradable magnesium alloy blood vessel rack consists of magnesium in 60-95 wt% and other metals, including RE, for the rest. Metal magnesium as the basic material has excellent tissue compatibility and blood compatibility, and the added other metal, including RE, elements raise and improve the comprehensive performance, especially mechanical strength, plasticity, degradability and biocompatibility. The magnesium alloy blood vessel rack has tensile strength of 200-300 MPa, elastic module of 10-50 GPa, elongation at break of 2-10%and degrading half life of 6-18 weeks. Most of the degraded metal ions are drained through renal tubules while small part being utilized by human body.

Description

technical field [0001] The invention relates to a vascular stent, in particular to a biodegradable magnesium alloy vascular stent applied to human hearts and brain vessels, and belongs to the field of biomedical engineering. technical background [0002] In foreign countries, the research on PTCA (percutaneous transluminal coronary angioplasty) was first carried out in 1977. The first case of PTCA in China was completed in 1984. Its mechanism of action is to deliver the balloon catheter to the coronary artery lesion, pressurize Inflate the balloon to increase the inner diameter of the stenotic vessel segment, thereby improving blood supply to the myocardium. Coronary artery stenting is developed on the basis of PTCA. It compresses the metal stent on the balloon to support the inner wall of the diseased or narrowed coronary artery, and expands the narrowed or collapsed vessel wall to a normal state. It is the current technology for the treatment of coronary heart disease. It...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L27/04A61L27/50A61L31/02A61F2/82
Inventor 李昕跃焦延鹏
Owner LIAONING YINYI BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap